Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Perifosine Granted Second Orphan Drug Status

July 15, 2010 7:46 am | News | Comments

Keryx Biopharmaceuticals Inc. said that its experimental cancer drug perifosine received orphan drug status as a treatment for neuroblastoma, a cancer that affects the nervous system and mostly strikes young children.


Lorcaserin Deemed Safe And Effective

July 15, 2010 7:40 am | by Mike Stobbe | News | Comments

An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.


Novartis Shelling Out $152M In Settlements

July 15, 2010 7:36 am | by Larry Neumeister | News | Comments

Novartis will pay up to $152.5 million to potentially thousands of women after a jury found it discriminated against them by paying them less than men, the pharmaceutical company and plaintiffs' lawyers announced Wednesday after a deal was struck.


FDA Panels Votes to Keep Avandia

July 15, 2010 7:33 am | by Matthew Perrone | News | Comments

GlaxoSmithKline's drug Avandia should stay on the market, federal health experts voted, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects.


Protease Assay

July 15, 2010 7:16 am | Product Releases | Comments

FLEXYTE protease assays harness the power and potential of fluorescence lifetime technology for robust, efficient and economical screening of proteases.


Fluorescing DNA Dye

July 15, 2010 7:11 am | Product Releases | Comments

DRAQ7 from Biostatus Ltd. is a live cell-impermeant far-red fluorescing DNA dye with the same spectral properties that already made DRAQ5 a reagent of choice.


Screening Method for Extra Large Libraries Developed

July 15, 2010 7:03 am | News | Comments

The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through—time and money make it virtually impossible to screen or search through super-large libraries of potential compounds.


Elemental Analyser

July 15, 2010 6:56 am | Product Releases | Comments

With its wide linear range, combined static and dynamic combustion technology and horizontal furnace design allowing for removal of residues between runs, the Exeter Analytical CE-440 CHN/O/S elemental analyzer is uniquely capable of accurately analyzing the widest range of sample types - quickly, easily and reliably.


ADME Simulator

July 15, 2010 6:44 am | Drug Discovery & Development | Product Releases | Comments

Simcyp Limited announced that it has released the latest version of its flagship simulator, further enhancing its position in modeling and simulation of drug-drug interactions (DDIs) in virtual populations.


Automated Synthesizer

July 15, 2010 6:33 am | Product Releases | Comments

Zinsser-Analytic and Thales Nano have teamed up to develop a highly flexible automated synthesizer which combines many functions on one platform.


Cell Research System

July 14, 2010 8:45 am | Product Releases | Comments

InQ Biosciences announced its plans to launch the InQTM Cell Research System, a fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and other mammalian cells for disease research.


Advanced Plating Module

July 14, 2010 8:39 am | Product Releases | Comments

The Automation Partnership (TAP) announced it has begun installations of its CompacT SelecT Advanced Plating Module, an alternative to the CompacT SelecT system which increase the flexibility of the plating system and enable researchers to produce consistent, high quality cell plates, ready for use in transport assays.


New White Paper on Combination Products

July 14, 2010 8:27 am | News | Comments

A new free, white paper that guides medical device manufacturers in the complicated process of applying new U.S. Food and Drug Administration (FDA) regulations to combination products embedded with pharmaceutical or biologic components is now available.


Sanofi-Novalar Anesthetic Being Reviewed

July 14, 2010 8:21 am | News | Comments

Sanofi-Aventis and Novalar Pharmaceuticals, Inc. announced that the Marketing Authorization Application for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom, Germany, Italy, France and Spain.


Pain And Depression Tackled Via Telephone

July 14, 2010 8:11 am | News | Comments

Pain and depression associated with cancer can be debilitating, but symptoms are often unrecognized and undertreated. These can be significantly reduced through centralized telephone-based care management coupled with automated symptom monitoring.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.